UK markets closed

4D pharma plc (DDDD.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
136.00-10.00 (-6.85%)
At close: 4:35PM GMT
Currency in GBp

Valuation measures

Market cap (intra-day) 5178.84M
Enterprise value 3139.98M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)367.98
Price/book (mrq)473.87
Enterprise value/revenue 3288.03
Enterprise value/EBITDA 6-4.24

Trading information

Stock price history

Beta (5Y monthly) 2.85
52-week change 3142.86%
S&P500 52-week change 323.92%
52-week high 3183.00
52-week low 323.50
50-day moving average 3127.29
200-day moving average 3116.40

Share statistics

Avg vol (3-month) 32.28M
Avg vol (10-day) 33.99M
Shares outstanding 5131.5M
Float 71.71M
% held by insiders 135.25%
% held by institutions 122.19%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-7,003.09%

Management effectiveness

Return on assets (ttm)-51.57%
Return on equity (ttm)-77.68%

Income statement

Revenue (ttm)486k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)211k
EBITDA -33.04M
Net income avi to common (ttm)-25.8M
Diluted EPS (ttm)-31.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.03M
Total cash per share (mrq)0.09
Total debt (mrq)1.1M
Total debt/equity (mrq)3.50
Current ratio (mrq)3.16
Book value per share (mrq)0.29

Cash flow statement

Operating cash flow (ttm)-22.56M
Levered free cash flow (ttm)-18.1M